Factor XI activation by meizothrombin: Stimulation by phospholipid vesicles containing both phosphatidylserine and phosphatidylethanolamine

Thrombosis and Haemostasis

Volumn 78, Issue 2, 1997, Pages 834-839

  Von Dem Borne, Peter A Kr ^a   Mosnier, Laurent O ^a   Tans, Guido ^b   Meijers, Joost C M ^a   Bouma, Bonno N ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 9A; DEXTRAN SULFATE; HEPARIN; MEIZOTHROMBIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; THROMBIN;

ARTICLE; BLOOD CLOT LYSIS; CENTRIFUGATION; CONTROLLED STUDY; FEEDBACK SYSTEM; HUMAN; PHOSPHOLIPID VESICLE; PLASMA; PRIORITY JOURNAL; STIMULATION;

EID: 0030792746     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657637     Document Type: Article

References (32)

1. Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 1991; 266: 7353-8.
2. Gailani D, Broze GJ. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-12.
3. Gailani D, Broze G J. Effects of glycosaminoglycans on factor XI activation by thrombin. Blood Coagul Fibrinolysis 1993; 4: 15-20.
4. Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. Thromb Haemost 1991; 65: 144 (Abstract).
5. Gailani D, Broze GJ. Factor XII-independent activation of factor XI in plasma: effect of sulfatides on tissue factor-induced coagulation. Blood 1993; 82: 813-19.
6. von dem Borne PAK, Koppelman SJ, Bouma BN, Meijers JCM. Surface independent activation of factor XI by thrombin in the presence of high molecular weight kininogen. Thromb Haemost 1994; 72: 397-402.
7. von dem Borne PAK, Meijers JCM, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 1995; 86: 3035-42.
8. Mann KG, Nesheim WR, Church WR, Haley P, Krishaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76: 1-16.
9. Mann KG, Krishnaswamy S, Lawson JH. Surface-dependent hemostasis. Semin Hematol 1992; 29: 213-26.
10. Rosing J, Tans G. Meizothrombin, a major product of factor Xa-catalyzed prothrombin activation. Thromb Haemost 1988; 60: 355-60.
11. Doyle M, Haley PE. Meizothrombin: active intermediate formed during prothrombinase-catalyzed activation of prothrombin. Methods Enzymol 1993; 222: 299-312.
12. Rosing J, Zwaal RFA, Tans G. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation. J Biol Chem 1986; 261: 4224-8.
13. Doyle MF, Mann KG. Multiple active forms of thrombin. IV. Relative activities of meizothrombins. J Biol Chem 1990; 265: 10693-701.
14. Tans G, Nicolaes GAF, Christella M, Thomassen LGD, Hemker HC, van Zonneveld AJ, Pannekoek H, Rosing J. Activation of human factor V by meizothrombin. J Biol Chem 1994; 269: 15969-72.
15. Schoen P, Lindhout T. The in situ inhibition of prothrombinase formed human α-thrombin and meizothrombin (desF1) by antithrombin III and heparin. J Biol Chem 1987; 262: 11268-74.
16. Krishnaswamy S, Mann KG, Nesheim ME. The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction. J Biol Chem 1986; 261: 8977-84.
17. Tijburg PNM, van Heerde WL, Leenhouts HM, Hessing M, Bouma BN, de Groot PhG. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation on endothelial cells. The influence of thrombin on the reaction mechanism. J Biol Chem 1991; 266: 4017-22.
18. Tans G, Janssen-Claessen T, Hemker HC, Zwaal RFA, Rosing J. Meizothrombin formation during factor Xa-catalyzed prothrombin activa-tion. Formation in a purified system and in plasma. J Biol Chem 1991; 266: 21864-73.
19. Bovill EG, Tracy RP, Hayes TE, Jenny RJ, Bhushan FH, Mann KG. Evidence that meizothrombin is an intermediate product in clotting whole blood. Arterioscler Thromb Vasc Biol 1995; 15: 754-8.
20. Miletich JP, Jackson CM, Majerus PW. Properties of the factor Xa binding site on platelets. J Biol Chem 1978; 253: 6908-16.
21. van der Graaf F, Greengard JS, Bouma BN, Kerbiriou DM, Griffin JH. Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI. J Biol Chem 1983; 258: 9669-75.
22. Ahmad SS, Rawala-Sheikh R, Walsh PN. Comparative interactions of factor IX and factor IXa with human platelets. J Biol Chem 1989; 264: 3244-51.
23. Brunner J, Skrabal P, Hauser H. Single bilayer vesicles prepared without sonication. Physico-chemical properties. Biochim Biophys Acta 1976; 455: 322-31.
24. Rouser G, Fleisher S, Yamamoto A. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipid by phosphorus analysis of spots. Lipids 1970; 5: 494-6.
25. Meijers JCM. Regulation of the blood coagulation mechanism by plasma proteinase inhibitors. PhD Thesis, State University of Utrecht, The Netherlands 1988; pp. 93-108.
26. Uchida T, Filburn CR. Affinity chromatography of protein kinase C-phorbol ester receptor on polyacrylamide-immobilized phosphatidylserine. J Biol Chem 1984; 259: 12311-4.
27. Rhee MJ, Morris S, Kosow DP. Role of meizothrombin and meizothrombin(desF1) in the conversion of prothrombin to thrombin by the Echis carinatus venom coagulant. Biochemistry 1988; 21: 3437-43.
28. Pei G, Laue TM, Aulabaugh A, Fowlkes DM, Lentz BR. Structural comparisons of meizothrombin and its precursor prothrombin in the presence or absence of membranes. Biochemistry 1992; 31: 6990-6.
29. Bevers EM, Comfurius P, Zwaal RFA. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736: 57-66.
30. Bevers EM, Comfurius P, Zwaal RFA. Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Rev 1991; 5: 146-54.
31. Neuenschwander PF, Bianco-Fisher E, Rezaie AR, Morrissey JH. Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine. Biochemistry 1995; 34: 13988-93.
32. Smirnov MD, Esmon CT. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem 1994; 269: 816-9.